Cargando…
Low-dose Oral Ketamine as a Procedural Analgesia in Pediatric Cancer Patients Undergoing Bone Marrow Aspirations at a Resource-limited Cancer Hospital in India
AIM: Many pediatric cancer patients undergo repeated bone marrow aspirations (BMAs) for diagnostic and treatment evaluation purposes. Full anesthesia is the standard of care during this procedure in high-income countries. At hospitals with low resources in low/middle-income countries many children u...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812415/ https://www.ncbi.nlm.nih.gov/pubmed/31673202 http://dx.doi.org/10.4103/IJPC.IJPC_110_19 |
_version_ | 1783462655233622016 |
---|---|
author | Rayala, Spandana Kyander, Melker Haridass, Vikranth Palat, Gayatri Ström, Axel Wiebe, Thomas Brun, Eva Segerlantz, Mikael |
author_facet | Rayala, Spandana Kyander, Melker Haridass, Vikranth Palat, Gayatri Ström, Axel Wiebe, Thomas Brun, Eva Segerlantz, Mikael |
author_sort | Rayala, Spandana |
collection | PubMed |
description | AIM: Many pediatric cancer patients undergo repeated bone marrow aspirations (BMAs) for diagnostic and treatment evaluation purposes. Full anesthesia is the standard of care during this procedure in high-income countries. At hospitals with low resources in low/middle-income countries many children undergo these painful procedures without sufficient pain relief. This study aimed to evaluate the usefulness of low-dose oral ketamine as a procedural analgesic in a low-resource pediatric cancer care department. MATERIALS AND METHODS: Pediatric patients, 4–15 years of age, who underwent BMAs between September 31 and November 30, 2018, were invited to participate. The study was designed as a placebo-controlled, single-blinded trial with three trial groups. Group K received 1.0 mg/kg of ketamine and Group KM received 1.0 mg/kg ketamine with an addition of 0.2 mg/kg midazolam, mixed in juice 30 min before procedures. Group P received placebo consisting of plain juice. All three groups also received the hospital's current standard treatment for procedural pain in BMAs. Patients and caregivers assessed the procedural pain, as did the performing doctors. For the patients, Faces Pain Scale – Revised was used and the Numeric Rating Scale-11 for caregivers and doctors. RESULTS: A total of 87 patients were included in the study distributed with 29 in Group K, 29 in Group KM, and 29 in Group P. Seven patients were excluded, one patient denied participation and the remaining did not meet the inclusion criteria. There was no significant difference between the pain reported by the groups. A total of 69% patients in Group KM and 35% in Group K had somnolence reported as a side effect compared to 14% in Group P. CONCLUSION: We found no significant effects on the procedural pain in any of the treatment groups compared to placebo. There were only mild side effects. The doses of ketamine might be insufficient for this painful and stressful procedure. |
format | Online Article Text |
id | pubmed-6812415 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-68124152019-10-31 Low-dose Oral Ketamine as a Procedural Analgesia in Pediatric Cancer Patients Undergoing Bone Marrow Aspirations at a Resource-limited Cancer Hospital in India Rayala, Spandana Kyander, Melker Haridass, Vikranth Palat, Gayatri Ström, Axel Wiebe, Thomas Brun, Eva Segerlantz, Mikael Indian J Palliat Care Original Article AIM: Many pediatric cancer patients undergo repeated bone marrow aspirations (BMAs) for diagnostic and treatment evaluation purposes. Full anesthesia is the standard of care during this procedure in high-income countries. At hospitals with low resources in low/middle-income countries many children undergo these painful procedures without sufficient pain relief. This study aimed to evaluate the usefulness of low-dose oral ketamine as a procedural analgesic in a low-resource pediatric cancer care department. MATERIALS AND METHODS: Pediatric patients, 4–15 years of age, who underwent BMAs between September 31 and November 30, 2018, were invited to participate. The study was designed as a placebo-controlled, single-blinded trial with three trial groups. Group K received 1.0 mg/kg of ketamine and Group KM received 1.0 mg/kg ketamine with an addition of 0.2 mg/kg midazolam, mixed in juice 30 min before procedures. Group P received placebo consisting of plain juice. All three groups also received the hospital's current standard treatment for procedural pain in BMAs. Patients and caregivers assessed the procedural pain, as did the performing doctors. For the patients, Faces Pain Scale – Revised was used and the Numeric Rating Scale-11 for caregivers and doctors. RESULTS: A total of 87 patients were included in the study distributed with 29 in Group K, 29 in Group KM, and 29 in Group P. Seven patients were excluded, one patient denied participation and the remaining did not meet the inclusion criteria. There was no significant difference between the pain reported by the groups. A total of 69% patients in Group KM and 35% in Group K had somnolence reported as a side effect compared to 14% in Group P. CONCLUSION: We found no significant effects on the procedural pain in any of the treatment groups compared to placebo. There were only mild side effects. The doses of ketamine might be insufficient for this painful and stressful procedure. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6812415/ /pubmed/31673202 http://dx.doi.org/10.4103/IJPC.IJPC_110_19 Text en Copyright: © 2019 Indian Journal of Palliative Care http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Rayala, Spandana Kyander, Melker Haridass, Vikranth Palat, Gayatri Ström, Axel Wiebe, Thomas Brun, Eva Segerlantz, Mikael Low-dose Oral Ketamine as a Procedural Analgesia in Pediatric Cancer Patients Undergoing Bone Marrow Aspirations at a Resource-limited Cancer Hospital in India |
title | Low-dose Oral Ketamine as a Procedural Analgesia in Pediatric Cancer Patients Undergoing Bone Marrow Aspirations at a Resource-limited Cancer Hospital in India |
title_full | Low-dose Oral Ketamine as a Procedural Analgesia in Pediatric Cancer Patients Undergoing Bone Marrow Aspirations at a Resource-limited Cancer Hospital in India |
title_fullStr | Low-dose Oral Ketamine as a Procedural Analgesia in Pediatric Cancer Patients Undergoing Bone Marrow Aspirations at a Resource-limited Cancer Hospital in India |
title_full_unstemmed | Low-dose Oral Ketamine as a Procedural Analgesia in Pediatric Cancer Patients Undergoing Bone Marrow Aspirations at a Resource-limited Cancer Hospital in India |
title_short | Low-dose Oral Ketamine as a Procedural Analgesia in Pediatric Cancer Patients Undergoing Bone Marrow Aspirations at a Resource-limited Cancer Hospital in India |
title_sort | low-dose oral ketamine as a procedural analgesia in pediatric cancer patients undergoing bone marrow aspirations at a resource-limited cancer hospital in india |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812415/ https://www.ncbi.nlm.nih.gov/pubmed/31673202 http://dx.doi.org/10.4103/IJPC.IJPC_110_19 |
work_keys_str_mv | AT rayalaspandana lowdoseoralketamineasaproceduralanalgesiainpediatriccancerpatientsundergoingbonemarrowaspirationsataresourcelimitedcancerhospitalinindia AT kyandermelker lowdoseoralketamineasaproceduralanalgesiainpediatriccancerpatientsundergoingbonemarrowaspirationsataresourcelimitedcancerhospitalinindia AT haridassvikranth lowdoseoralketamineasaproceduralanalgesiainpediatriccancerpatientsundergoingbonemarrowaspirationsataresourcelimitedcancerhospitalinindia AT palatgayatri lowdoseoralketamineasaproceduralanalgesiainpediatriccancerpatientsundergoingbonemarrowaspirationsataresourcelimitedcancerhospitalinindia AT stromaxel lowdoseoralketamineasaproceduralanalgesiainpediatriccancerpatientsundergoingbonemarrowaspirationsataresourcelimitedcancerhospitalinindia AT wiebethomas lowdoseoralketamineasaproceduralanalgesiainpediatriccancerpatientsundergoingbonemarrowaspirationsataresourcelimitedcancerhospitalinindia AT bruneva lowdoseoralketamineasaproceduralanalgesiainpediatriccancerpatientsundergoingbonemarrowaspirationsataresourcelimitedcancerhospitalinindia AT segerlantzmikael lowdoseoralketamineasaproceduralanalgesiainpediatriccancerpatientsundergoingbonemarrowaspirationsataresourcelimitedcancerhospitalinindia |